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Abstract
Background—Asthma morbidity is increased among older adults, especially older adult women. 
Interventions to improve asthma control in this population are not well-described.
Objective—Identify risk factors (including modifiable factors) associated with asthma-related 
hospitalizations and emergency department or urgent care center visits (ED/UCV) among older 
adults. A secondary objective was to investigate sex differences in variables relevant to asthma 
control.
Methods—Data were obtained from 14,076 older adults ≥65 years with active asthma 
participating in the 2006–2010 Behavioral Risk Factor Surveillance System Asthma Call-back 
Survey (a random-digit dialed survey) in 40 U.S. states, the District of Columbia, and Puerto Rico, 
representative of >2.6 million persons. Weighted, adjusted logistic regression was conducted.
Results—≥1 asthma-related hospitalizations in the past year were reported by 5.7% (95% 
confidence interval [95% CI]=5.0–6.4%) of participants; 10.6% (95% CI=9.7–11.5%) reported ≥1 
asthma-related ED/UCV. Compared to older adults without asthma-related hospitalizations, 
adjusted odds were higher among those with ≥1 asthma-related hospitalization for chronic 
obstructive pulmonary disease (COPD), coronary artery disease, depression, cockroaches or mold 
in the home, and cost barriers to asthma-related health care or medication. All these factors, except 
for cockroaches, were associated with asthma-related ED/UCV. Compared to males, adjusted odds 
were higher among females for COPD, depression, obesity, and cost barriers to asthma-related 
health care or medication.
Conclusions—Among older adults, asthma-related hospitalizations and ED/UCV were 
associated with clinical comorbidities, mold in the home, and financial barriers to asthma-related 
health care. Interventions addressing modifiable factors could reduce asthma morbidity among 
older adults.
Corresponding author: Joy Hsu, MD, MS, Air Pollution and Respiratory Health Branch, Division of Environmental Hazards and 
Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, 4770 Buford Highway 
Mailstop F-60, Atlanta, GA, 30341, telephone 770-488-0788, fax 770-488-1540, xdd6@cdc.gov. 
Conflict of interest: No conflicts of interest were reported by the authors of this paper
Financial disclosure: No financial disclosures were reported by the authors of this paper
HHS Public Access
Author manuscript
J Allergy Clin Immunol Pract. Author manuscript; available in PMC 2019 January 01.
Published in final edited form as:
J Allergy Clin Immunol Pract. 2018 ; 6(1): 236–243.e7. doi:10.1016/j.jaip.2017.06.007.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Keywords
asthma; older adults; elderly; health care utilization; environment; cockroach; mold; cost; chronic 
obstructive pulmonary disease; depression
INTRODUCTION
The number of older adults is rapidly growing worldwide.1, 2 In the United States alone, the 
number of U.S. adults aged ≥65 years (hereafter referred to as “older adults”) will more than 
double by 2030 to approximately 71 million.2 Although the prevalence of asthma in this age 
group is comparable to that of the general adult population,3 data on asthma-related 
hospitalizations and deaths indicate asthma morbidity and mortality are higher among older 
adults.1, 4–7 The burden of asthma is especially high among older adult women.7
Asthma among older adults is a topic under active investigation, and many unanswered 
questions remain.1, 8 Targeted interventions to improve asthma control and decrease asthma 
burden in this population are not well-described. Limited data exist on barriers to adherence 
and other potentially modifiable factors related to asthma morbidity among older adults (for 
example, environment factors).1, 8–10
This study analyzed 2006–2010 data on older adults in 40 U.S. states, the District of 
Columbia, and Puerto Rico to identify risk factors associated with asthma-related 
hospitalizations, with a focus on potentially modifiable factors. Another indicator of 
morbidity — risk factors associated with asthma-related emergency department or urgent 
care center visits (ED/UCV), including potentially modifiable factors — was also examined. 
Lastly, because female sex is a known risk factor for increased asthma morbidity among 
older adults7, secondary analyses explored how this disparity might be related to sex 
differences in other variables relevant to asthma control.
METHODS
Asthma Call-back Survey
Data were analyzed from the 2006–2010 Behavioral Risk Factor Surveillance System 
(BRFSS) and the BRFSS Adult Asthma Call-back Survey (ACBS).11, 12 BRFSS is an 
ongoing, state-based, random-digit-dialed telephone survey of non-institutionalized U.S. 
adults aged ≥18 years.11 Before 2011, BRFSS interviews were conducted by landline 
telephone.11 Detailed information about BRFSS’ multistage sampling design and sample 
weighting is available elsewhere.11 ACBS is a follow-up telephone survey administered to 
BRFSS participants who indicated that they ever had asthma (i.e., they responded ‘yes’ to 
the question, “have you ever been told by a doctor, nurse, or other health professional that 
you had asthma?”).13 ACBS is conducted approximately two weeks after BRFSS.13 
Jurisdiction-specific Institutional Review Board (IRB) requirements apply to each 
participating state, territory, and the District of Columbia; informed consent was obtained.13 
Analyses of BRFSS and ACBS data are exempt from review by the IRB at the Centers for 
Disease Control and Prevention.
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To obtain a sufficiently large sample to produce stable estimates, Adult BRFSS and ACBS 
data were combined from 2006–2010.13 Data were weighted to represent adults aged ≥18 
years with asthma from 40 states, the District of Columbia, and Puerto Rico (i.e., U.S. areas 
from which Adult BRFSS and ACBS data were available during 2006–2010).12 Additional 
information on participating states, weight calculations, and response rates is located online 
and in prior publications.12, 14, 15
Study Sample
This study was focused on adults aged ≥65 years with active asthma (Figure 1). As in 
previous analyses of BRFSS and ACBS data,16–18 respondents were classified as having 
active asthma if they reported in ACBS that at least one of the following occurred during the 
past 12 months: talked to a doctor or other health professional about his or her asthma, took 
asthma medication, or experienced any symptoms of asthma.
For background information, the study population of adults aged ≥65 years with active 
asthma was compared to adults aged 18–64 years with active asthma (Online Repository 
Table E1). The same definition for active asthma was applied to both groups.
BRFSS Variables
Respondent characteristics obtained from BRFSS data were age (at time of interview), sex, 
race/ethnicity, U.S. census region, annual household income, and smoking history. Smoking 
history was assessed using responses to the questionnaire item, “Have you smoked at least 
100 cigarettes in your entire life?”
Clinical comorbidity information regarding coronary artery disease (CAD), diabetes, and 
obesity were obtained from BRFSS data. Respondents were classified with CAD if they 
answered “yes” to ≥1 of the following two questionnaire items: “Has a doctor, nurse, or 
other health professional ever told you that you had a heart attack, also called a myocardial 
infarction?” or “Has a doctor, nurse, or other health professional ever told you that you had 
angina or coronary heart disease?” History of diabetes was determined using the 
questionnaire item “Has a doctor, nurse, or other health professional ever told you that you 
had diabetes?” Gestational diabetes, prediabetes, and borderline diabetes were not included 
in the definition of diabetes for this analysis. Individuals with a body mass index (BMI) ≥30 
kg/m2 calculated from their reported height and weight were categorized as obese.
ACBS Variables
Characteristics obtained from ACBS responses included time since asthma diagnosis and 
asthma medication use in the past three months. Time since asthma diagnosis was 
determined from the questionnaire item, “How long ago was it [when you were first told by 
a doctor or other health professional that you had asthma]?” Asthma medication use in the 
past three months was classified into four categories: none, short-acting β agonist (SABA) 
only, ≥1 asthma controller medication (i.e., inhaled corticosteroids, long-acting β agonists, 
leukotriene modifiers, methylxanthines, cromolyn, nedocromil, or immunomodulators), and 
oral corticosteroid only (without SABA or asthma controller medication[s]).
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Asthma control was assessed using previously published methods that were adapted from 
the 2007 National Asthma Education and Prevention Program Guidelines for the Diagnosis 
and Management of Asthma (EPR-3) and account for the ACBS design (Table E2).14, 19, 20 
Briefly, three impairment measures were assessed: daytime symptoms, night-time 
symptoms, and SABA use (other than for preventing exercise-induced bronchospasm) 
during the past three months. Asthma control was defined using the highest impairment level 
identified for each adult across these three measures.
Asthma severity was measured according to EPR-3 guidelines and previously published 
methods, which classified asthma severity using information on asthma control and 
controller medication use.15, 19, 20 Briefly, respondents whose asthma was well controlled 
without asthma controller medication use in the past three months were categorized as 
having intermittent asthma. Persistent asthma included all respondents who reported using 
asthma controller medication (regardless of asthma control status) and respondents not 
reporting asthma controller medication use but meeting criteria for not well controlled or 
very poorly controlled asthma. Additional information on defining asthma control and 
severity using ACBS data is available in prior publications.14, 15, 20
Information on asthma-related hospitalizations was obtained from the questionnaire item, 
“During the past 12 months, that is since [1 year ago today], have you had to stay overnight 
in a hospital because of your asthma? Do not include an overnight stay in the emergency 
room.” Information on asthma-related ED/UCV was obtained from the questionnaire item, 
“During the past 12 months, have you had to visit an emergency room or urgent care center 
because of your asthma?”
Regarding clinical comorbidities, ACBS data were used to identify respondents with a 
history of chronic obstructive pulmonary disease (COPD) or depression. Respondents were 
classified with COPD if they answered “yes” to ≥1 of the following three questionnaire 
items: “Have you ever been told by a doctor or health professional that you have chronic 
obstructive pulmonary disease, also known as COPD?”, “Have you ever been told by a 
doctor or other health professional that you have emphysema?”, or “Have you ever been told 
by a doctor or other health professional that you have chronic bronchitis?” History of 
depression was determined using the questionnaire item “Have you ever been told by a 
doctor or other health professional that you were depressed?”
Regarding potentially modifiable factors, cost as a barrier to health care was investigated 
using questionnaire responses concerning inability to buy medication, see a primary care 
physician, or see a specialist for asthma in the past 12 months. Home environment variables 
were related to secondhand smoke, pets allowed in respondents’ bedrooms, reports of seeing 
or smelling mold in the home in the past 30 days, and report of seeing cockroaches, mice, or 
rats inside the home in the past 30 days.
As in previous analyses, uninformative responses (i.e., don’t know, missing, refused) were 
considered negative responses (i.e., not having the relevant outcome).16, 18, 20, 21
Hsu et al. Page 4
J Allergy Clin Immunol Pract. Author manuscript; available in PMC 2019 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Statistical Analysis
Sampling weights were used to calculate population estimates representative of 40 states, the 
District of Columbia, and Puerto Rico (Table E2). These sampling weights accounted for 
BRFSS and ACBS nonresponse and unequal sampling probabilities.17 To properly account 
for the complex sample survey design, the entire dataset (N = 74,209 ever diagnosed with 
asthma) was retained in the final analyses. Given this investigation’s focus on adults aged 
≥65 years with active asthma, only results generated from the stratum of the population of 
14,076 older adults with active asthma (Figure 1) are presented in the main tables.
Complex sample survey procedures were used to compare continuous and categorical 
variables (PROC SURVEYMEANS and PROC SURVEYFREQ in SAS, respectively).22, 23 
Multivariate logistic regression was performed to calculate odds ratios and 95% confidence 
intervals (CIs) for associations between asthma-related hospitalizations or ED/UCV and all 
variables of interest; results were adjusted for sex, race/ethnicity, annual household income, 
smoking history, and asthma severity. Statistical significance was set at a P value <0.05. 
Results based on <50 unweighted respondents (i.e., percentages based upon a denominator 
<50) or for which the relative standard error (standard error/prevalence estimate; a measure 
of an estimate’s reliability) was >0.3 were suppressed.12 Identical procedures were used in 
secondary analyses examining potential sex differences in variables relevant to asthma 
control, as well as sensitivity analyses (stratification by COPD status; modified active 
asthma definition using a 3-month time frame for asthma medication use instead of the 
conventional 12-month time frame). These analyses were conducted in SAS version 9.3 
(SAS Institute Inc., Cary, NC).
Population attributable fractions (PAFs) were calculated using the formula PAF = 
(p[RR-1])/(p[RR-1]+1), where RR is the relative risk and p is the proportion of the study 
population with the risk factor; RR was estimated by the adjusted OR. Similarly, PAF 95% 
CIs were estimated using adjusted OR 95% CIs.
RESULTS
In this study, 14,076 unique older adults (≥65 years) with active asthma were identified 
(Figure 1). Because sampling weights were incorporated into these analyses, this study 
population represents over 2.6 million older adults. Of this study population, 5.7% (95% 
CI=5.0–6.4%) reported ≥1 asthma-related hospitalization and 31.9% (95% CI=30.1–33.5%) 
reported ≥1 asthma-related ED/UCV in the past year. Compared to adults aged 18–64 years, 
older adults were more likely to have asthma-related hospitalizations, very poorly controlled 
asthma, persistent asthma, and medication regimens with ≥1 asthma controller (Table E1). 
Asthma-related ED/UCV and work-related asthma diagnosed by a health professional were 
less common among older adults.
Asthma-Related Hospitalizations Among Older Adults
The percentage of older adults with ≥1 asthma-related hospitalization varied significantly by 
geographic region (P=.03; Table I). Compared to older adults with no asthma-related 
hospitalizations in the past year, those with ≥1 asthma-related hospitalization were more 
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likely to be Black, female, and report annual household incomes <$25,000. Additional 
demographic information is presented in Figure E1. Persistent asthma, very poorly 
controlled asthma, and use asthma controller medication was more common among older 
adults with ≥1 asthma-related hospitalization. The two groups did not differ significantly in 
smoking history (P=.06) or age (weighted average ± standard error=73.1±0.5 years for ≥1 
asthma-related hospitalization vs. 73.4±0.1 years for no asthma-related hospitalizations, P=.
5).
In multivariate analyses (Table II), asthma-related hospitalizations among older adults were 
associated with COPD, CAD, depression, and diabetes, but not obesity. Compared to older 
adults without asthma-related hospitalizations, adjusted odds were higher among older 
adults with asthma-related hospitalization(s) for being unable to see a primary care doctor 
for asthma, see a specialist for asthma, or buy medication for asthma because of cost. Also, 
signs of mold or cockroaches in the home were associated with asthma-related 
hospitalizations. Estimates of PAFs (Table E3) indicated the variable with the largest overall 
PAF was COPD (0.63; 95% CI=0.50–0.73); of modifiable factors examined, the largest PAF 
was associated with financial barriers to buying asthma medication (0.14; 95% CI=0.08–
0.21).
Asthma-Related Emergency Department or Urgent Care Center Visits (ED/UCV) Among 
Older Adults
Factors associated with asthma-related ED/UCV were similar to those for hospitalizations 
(Table III). COPD, CAD, depression, and diabetes were more common among older adults 
with ≥1 asthma-related ED/UCV, as were the inability to see a primary care doctor for 
asthma, see a specialist for asthma, or buy medication for asthma because of cost. Compared 
to older adults without asthma-related ED/UCV, adjusted odds were higher among older 
adults with asthma-related ED/UCV for signs of mold in the home. In contrast to asthma-
related hospitalizations, asthma-related ED/UCV were not significantly associated with 
cockroaches in the home.
Sensitivity Analyses
A sensitivity analysis of older adults with asthma but not COPD (n = 7,725) indicated 
financial barriers to asthma-related health care were significantly associated with asthma-
related hospitalizations, but clinical comorbidities and home environment conditions were 
not (Table E4). In this population, obesity was the only variable examined that was found to 
be associated with asthma-related ED/UCV. Among older adults with both asthma and 
COPD (n = 6,351), CAD and financial barriers to asthma-related health care were 
significantly associated with asthma-related hospitalizations; besides these variables, 
depression was also associated with asthma-related ED/UCV in this population. Results 
from a sensitivity analysis using a modified definition of active asthma yielded results 
similar to the main analyses (Table E5), except diabetes and home environment conditions 
were not significantly associated with asthma-related hospitalizations or ED/UCV.
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Sex Differences Among Older Adults
Compared to older men with active asthma, older women with active asthma were more 
likely to be Black and report annual household incomes <$25,000 (Table E6). The frequency 
of well controlled asthma was similar among men and women (40.2% [95% CI=37.2–
43.2%] vs. 39.0% [95% CI=37.2–40.9%], respectively). Not well controlled asthma was 
more common among women (28.2% [95% CI=26.5–29.8%], compared to 23.5% [95% 
CI=21.0–26.0%] among men). In contrast, very poorly controlled asthma was more common 
among men (36.3% [95% CI=33.3–39.3%], compared to 32.8% [95% CI=31.1–34.5%] 
among women). Asthma medication use, asthma severity, and (weighted) average age did 
not differ significantly by sex. Men were more likely than women to report a lifetime 
smoking history of ≥100 cigarettes.
Compared to male older adults, adjusted odds were higher among female older adults for 
COPD, depression, and obesity (Table E7). In contrast, adjusted odds were lower among 
female older adults for CAD. Female sex among older adults was associated with being 
unable to see a primary care doctor for asthma or buy medication for asthma because of cost. 
No sex differences in home environment variables were observed.
DISCUSSION
In a survey of older adults with active asthma from 40 U.S. states, the District of Columbia, 
and Puerto Rico, multivariate analyses revealed that clinical comorbidities, financial barriers 
to care, and selected home environment conditions were significantly associated with 
asthma-related hospitalizations or ED/UCV. This investigation identified new associations 
between asthma morbidity and several potentially modifiable factors among older adults. 
These findings are representative of >2.6 million older adults with active asthma. This study 
population is one of the largest samples of older adults with asthma to date.
For clinicians caring for this population in the acute or chronic setting, asthma-related 
hospitalizations or ED/UCV might prove helpful for identifying older adults with asthma 
who could benefit from an assessment of their need for home mold remediation, case 
management, integrated pest management (for asthma-related hospitalizations), or other 
interventions recommended by the EPR-3.19, 25 These findings could also be useful in 
informing public health or health care delivery. The associations between financial barriers 
to care and asthma morbidity identified herein are also notable because similar associations 
have been previously reported for older adults with other chronic conditions (COPD, cancer, 
cardiac disease) but had not yet been reported for asthma.7
This study’s findings regarding clinical comorbidities associated with asthma-related 
hospitalizations and ED/UCV support and extend prior literature. Individuals with both 
asthma and COPD (i.e., overlap) typically experience more frequent and severe 
exacerbations of these conditions.26 Depression has been associated with presence of asthma 
and worse asthma control among older adults; these results indicate asthma-related 
hospitalizations and ED/UCV are additional concerns for older adults with concomitant 
asthma and depression.1, 7, 27 Prior studies have reported heart disease and diabetes to be 
more prevalent among adults with asthma compared to adult controls1, 27–29, but older adults 
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comprised a minority in these study populations and asthma-related hospitalizations or 
ED/UCV were not examined.28, 29
Current evidence suggests obesity is a risk factor for development of asthma and can affect 
asthma control30, 31, but very little is known about the relationship between obesity and 
asthma in older adults.32 Higher BMI was associated with current asthma in a Korean study 
of adults aged ≥65 years, but few participants were classified with current asthma (5.4%).32 
An analysis of 2006–2010 Medical Expenditure Panel Survey data on adults aged ≥65 years 
found obesity to be a significant predictor of asthma-related costs (including inpatient, 
outpatient, emergency department, and prescription costs).33 Further specificity regarding 
the relationship between obesity and costs in selected settings (e.g., inpatient vs. outpatient) 
was not reported.33 Given the present study’s findings that obesity was not significantly 
related to asthma-related hospitalizations or ED/UCV, these previously reported, obesity-
related medical expenditures among older adults with asthma might be attributable to 
medical claims other than hospitalizations or ED/UCV.
Our secondary analysis of sex differences in demographic, clinical, and potentially 
modifiable characteristics support and expand current understanding of how these factors 
could relate to the disproportionately high burden of asthma among older women compared 
to older men.4,7 Concomitant asthma and COPD has been associated with female sex;34 
depression and obesity have been identified as comorbidities of particular concern among 
older women.7 Poverty is more common among older women than older men, and this study 
is the first to directly link female sex to cost barriers in buying asthma medication or seeing 
a primary care doctor for asthma among older adults. Frequently, the causes of 
nonadherence are multifactorial7; nevertheless, these results strengthen the evidence for how 
poverty can contribute to sex differences in asthma burden among older adults.
Several limitations might affect interpretation of results reported herein. Survey data were 
cross-sectional, so causality cannot be inferred and temporal proximity between asthma-
related health care utilization and other variables could not be assessed. Survey design 
limited how variables could be defined, such as smoking history, depression, and asthma 
control. These findings cannot be generalized to older adults in the 10 states not included in 
this dataset or those without household access to landline telephones. Non-response bias was 
possible, but sampling and weighting procedures helped diminish the potential impact on 
results. Collider bias24, 35 might have affected our results regarding relationships between 
health care access (e.g., cost as a barrier to seeing a doctor for asthma) and asthma-related 
hospitalizations or ED/UCV, because the selection of individuals with active asthma was 
partially predicated on potentially overlapping attributes (e.g., talked to a doctor or other 
health professional about asthma in the past 12 months).16–18 The content of the BRFSS and 
ACBS questionnaires limited investigation of other potential contributors to asthma 
morbidity and precluded distinguishing between emergency department and urgent care 
center visits. Data on IgE sensitization were not collected. Furthermore, self-reported 
diagnoses of asthma and clinical comorbidities could not be confirmed through medical 
chart review or other means. Lastly, an important caveat for interpreting PAF results was that 
the unit of analysis in the dataset was persons rather than episodes of health care utilization.
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In conclusion, this study analyzed data on older adults with active asthma from 40 U.S. 
states, the District of Columbia, and Puerto Rico and found multiple risk factors, including 
potentially modifiable factors (financial barriers to asthma-related health care, home 
environment), to be significantly associated with asthma-related hospitalizations or ED/
UCV. A secondary analysis revealed sex-related cost barriers to asthma-related health care 
that could be related to the previously reported higher burden of asthma among older women 
compared to older men. Together, these findings advance understanding of asthma among 
older adults and highlight potential opportunities to reduce asthma morbidity. Further 
investigation into targeted interventions for older adults with asthma could establish how to 
most effectively improve asthma control and reduce asthma disparities in this growing 
population.
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PAF population attributable fraction
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Highlights box
1. What is already known about this topic? Asthma morbidity is increased 
among older adults, especially older adult women.
2. What does this article add to our knowledge? Multivariate analyses of survey 
data (representative of 40 states, Washington, DC, and Puerto Rico) found 
associations between urgent asthma-related health care utilization by older 
adults and health care access, mold in the home, and comorbidities.
3. How does this study impact current management guidelines? Urgent 
asthma-related health care utilization by older adults could represent 
opportunities to improve asthma control through interventions addressing 
modifiable factors (e.g., case management, assessment or remediation of the 
home environment).
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FIGURE 1. 
Study Population: Behavioral Risk Factor Surveillance System Asthma Call-Back Survey of 
Adults (Aged ≥18 Years), 2006–2010
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